This study was conducted additionally to a previous study by Imai et al., “Efficacy and safety of cytotoxic drug chemotherapy after first-line EGFR-TKI treatment in elderly patients with non-small-cell lung cancer harboring sensitive EGFR mutations” [19]. Here, EGFR is linked to non-small cell lung carcinoma.